EP3519422
C7 SUBSTITUTED OXYSTEROLS AND THESE COMPOUNDS FOR USE AS NMDA MODULATORS
:
EP einkaleyfi: Þýðing ekki lögð inn:
30.9.2017:
31.8.2022:
17784770.4
:
29.9.2037
:
C7 SUBSTITUTED OXYSTEROLS AND THESE COMPOUNDS FOR USE AS NMDA MODULATORS
30.9.2017
31.8.2022
:
Sage Therapeutics, Inc.:
215 First Street, Cambridge, MA 02142, US
:
SALITURO, Francesco, G.:
Marlborough, MA 01752, US
:
ROBICHAUD, Albert, J.:
Cambridge, MA 02141, US
:
MARTINEZ BOTELLA, Gabriel:
Wayland, MA 01778, US
:
GRIFFIN, Andrew:
L'Ile Bizard, Quebec H9C 2Y, CA
:
HARRISON, Boyd, L.:
Princeton Junction, NJ 08550, US
:
LA, Daniel:
Cambridge, MA 02142, US
:
201662402789 P:
30.9.2016:
US
:
201662402797 P:
30.9.2016:
US
:
US2017054657:
30.9.2017
:
C07J 9/00, C07J 41/00, C07J 31/00, C07J 7/00, A61P 25/00, A61K 31/575, A61P 1/00, A61P 1/04, A61P 1/10, A61P 3/00, A61P 3/10, A61P 9/14, A61P 17/06, A61P 19/02, A61P 19/08, A61P 23/00, A61P 25/04, A61P 25/08, A61P 25/14, A61P 37/06, A61P 35/00, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24, A61P 25/28, A61P 25/30, A61P 27/16, A61P 29/00, A61P 25/16